Por: The Boston Globe Business November 15, 2022
A Boston biotech founded by researchers at the Broad Institute of MIT and Harvard has landed $157 million for its big plans to develop pills for cancer, immune conditions, neurological diseases, and a rare metabolic disorder.Jnana Therapeutics announced Tuesday that it raised a $107 million series C financing, more than doubling the $100 million it raised in its previous two rounds. Jnana also struck its second drug discovery collaboration with... + full article
The Boston Globe USA Business November 11, 2022
Barely a year after he was named head of the Massachusetts Biotechnology Council, former state Senator Joseph Boncore has been ousted and will be replaced with the trade group’s second-highest executive, according to two members of the nonprofit organization’s board of... + más
Is Boston reaching ‘peak lab’? | The Boston Globe
Pokemon Scarlet and Violet November 2022 trade codes | Newsweek
The Boston Globe USA Business October 20, 2022
PROVIDENCE — In the nearly four decades Neil Steinberg has been working in downtown Providence, he’s heard hype of a “spillover” effect from Boston to Providence when it comes to the life sciences industry.He watched as Cambridge, Massachusetts; Manchester, New... + más
Nobel Prize in economic sciences goes to former U.S. Federal Reserve chairman and American economists | New York Daily News
Tech insiders have a lot to say about the local startup scene. Most of it is good. | The Boston Globe
Forbes USA Life October 19, 2022
GANNI launches plant-based glitter in collaboration with Submission BeautyCourtesy of GANNI Launching on October 19 on and in stores worldwide, the limited capsule collection of plant-based glitters in collaboration with marks the Danish affordable luxury brand’s first-ever... + más
The Glitter Boys keep disco alive on Fridays at the Sinclair | The Boston Globe
Fall’s Must-Have Beauty Products Bottle up Fashion History | Vanity Fair
The Boston Globe USA Tech October 13, 2022
LabCentral, a biotech incubator that has fostered hundreds of startups at its shared lab spaces in Cambridge, is tripling its footprint with a new 100,000-square-foot lab, office, and manufacturing facility. The site, which is opening at a time when lab leases are commanding... + más
In a work-from-anywhere world, how will Kendall Square adapt for the future? | The Boston Globe
Broad scales up as Biogen scales back in Kendall Square | The Boston Globe
MarketWatch USA Business October 03, 2022
For Biogen, a failure would have revived talk of breaking up the biotech, while positive results may lead to a megablockbuster drug—and make it easier to hire a new CEO to replace exiting Michel Vounatsos. analyst Salim Syed wrote that he is modeling $8 billion in peak annual... + más
How To Spot The Early Signs Of Alzheimer's | Newsweek
COVID-19 in seniors linked to increased Alzheimer’s risk, study finds | Portland Press Herald
MarketWatch USA Business October 01, 2022
For Biogen, a failure would have revived talk of breaking up the biotech, while positive results may lead to a megablockbuster drug—and make it easier to hire a new CEO to replace exiting Michel Vounatsos. Mizuho analyst Salim Syed wrote that he is modeling $8 billion in peak... + más
About iurex | Privacy Policy | Disclaimer |